ChickenStockChickenStock

AI English summary of an SEC filing — figures as filed

Medtronic logoMedtronic MDT

The company said its revenue for FY25 Q1 (quarter ended July 26) was $7.915 billion, adjusted revenue was $8.004 billion, and revenue increased 2.8% as reported and 5.3% organically.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said its revenue for FY25 Q1 (quarter ended July 26) was $7.915 billion, adjusted revenue was $8.004 billion, and revenue increased 2.8% as reported and 5.3% organically.

  2. The company reported GAAP net income of $1.042 billion and GAAP diluted EPS of $0.80 for Q1, up 32% and 36% respectively. It reported non-GAAP net income of $1.592 billion, flat, and non-GAAP diluted EPS of $1.23, up 3%. The company said non-GAAP diluted EPS included a -6-cent impact from foreign currency translation.

  3. The company said it raised its organic revenue growth outlook for FY25 to 4.5% to 5%, from 4% to 5%, and its non-GAAP diluted EPS outlook to $5.42 to $5.50, from $5.40 to $5.50. It said the foreign currency impact of -5% was unchanged from its prior outlook.

  4. The company reported cash flow from operating activities of $986 million for Q1, capital expenditures of $520 million, and free cash flow of $466 million, compared with $521 million a year earlier. In the same period, it used $2,492 million to repurchase ordinary shares and received $3,209 million from long-term debt issuance.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q1 Revenue and Organic Growth

The company said its revenue for FY25 Q1 (quarter ended July 26) was $7.915 billion, adjusted revenue was $8.004 billion, and revenue increased 2.8% as reported and 5.3% organically.

Source · Based on the filing body and exhibits

GAAP and Non-GAAP Diluted EPS

The company reported GAAP net income of $1.042 billion and GAAP diluted EPS of $0.80 for Q1, up 32% and 36% respectively. It reported non-GAAP net income of $1.592 billion, flat, and non-GAAP diluted EPS of $1.23, up 3%. The company said non-GAAP diluted EPS included a -6-cent impact from foreign currency translation.

Source · Based on the filing body and exhibits

FY25 Organic Revenue Growth and EPS Outlook

The company said it raised its organic revenue growth outlook for FY25 to 4.5% to 5%, from 4% to 5%, and its non-GAAP diluted EPS outlook to $5.42 to $5.50, from $5.40 to $5.50. It said the foreign currency impact of -5% was unchanged from its prior outlook.

Source · Based on the filing body and exhibits

Q1 Cash Flow and Share Repurchases

The company reported cash flow from operating activities of $986 million for Q1, capital expenditures of $520 million, and free cash flow of $466 million, compared with $521 million a year earlier. In the same period, it used $2,492 million to repurchase ordinary shares and received $3,209 million from long-term debt issuance.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.